Can Novavax Stock Double in 2022?
Once upon a time, Novavax (NASDAQ: NVAX) ranked as the hottest COVID-19 vaccine stock around. These days, Novavax is anything but hot. Its shares are down more than 40% so far this year and more than 70% below their 52-week high.
Some might have written Novavax off as a lost cause. But can this beaten-down stock double in 2022?
Image source: Getty Images.
Source Fool.com